Dr. Pamela Zeitlin, a professor of pediatrics at the Johns Hopkins Children's Center at the Johns Hopkins Hospital in Baltimore, Maryland, discusses the impact that the 2009 American Recovery and Reinvestment Act has had on her research directed at finding an alternative gene as a treatment target for cystic fibrosis.
Link to this comment:
All Comments (0)